A Translational Study of Tumor Antigen-pulsed DC Vaccine for ESCC

Clinical trial NCT05317325 · UNKNOWN

Trial details

NCT number: NCT05317325
Sponsor: Sichuan University
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma

Start date: 2022-04-01
Primary completion: 2023-12-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.